Endometriosis News and Research

Latest Endometriosis News and Research

Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulthood

Prenatal exposure to bisphenol A, or BPA, a chemical found in many common plastic household items, can cause numerous genes in the uterus to respond differently to estrogen in adulthood, according to a study using a mouse model. The results will be presented Tuesday at The Endocrine Society's 94th Annual Meeting in Houston.

27 Jun 2012

Ampio’s CRO completes Optina clinical trial for DME

Ampio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, whose lead drugs treat inflammatory diseases, including osteoarthritis and complications of Diabetes Mellitus such as diabetic macular edema (and others) announced today that it's CRO has completed analysis of the primary end point in the Optina clinical trial for DME conducted at St Michael Diabetes Hospital in Toronto Canada.

11 Jun 2012

Abbott commences elagolix Phase 3 trial in endometriosis

Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

6 Jun 2012

Urocortin 2 improves cardiac output in Phase II study for acute decompensated heart failure

Neurocrine Biosciences, Inc. today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure. The UNICORN study was conducted over approximately a two year period by the Cardioendocrine Research Group from the University of Otago in Christchurch, New Zealand and included patients admitted to Christchurch Hospital with acute decompensated heart failure.

18 May 2012

KLF15 molecule inhibits action of estrogen in the endometrium

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a molecule that inhibits the action of estrogen. This female hormone plays a key role in the growth, maintenance and repair of reproductive tissues and fuels the development of endometrial and breast cancers.

10 May 2012

BP sunscreens may increase risk of endometriosis in women

Scientists are reporting a possible link between the use of sunscreen containing a certain ingredient that mimics the effects of the female sex hormone estrogen and an increased risk of being diagnosed with endometriosis, a painful condition in which uterine tissue grows outside the uterus. They describe the report, published in ACS' journal Environmental Science & Technology, as the first to examine whether such a connection may exist.

10 May 2012

Uterine cancer deaths rise 20% in the last decade

Deaths from womb (uterine) cancer have risen by nearly twenty per cent in the last decade, according to new figures from Cancer Research UK today.

5 Apr 2012

State lawmakers consider abortion, contraception legislation; Other states deal with fallout

A bill in Arizona would allow employers to deny contraception coverage on religious grounds and a Tenn. bill would require the state publish the names of doctors who perform abortions.

21 Mar 2012

Roundup: States face new revenue downturn; Calif. county has disparities in life expectancy

Revenues in most U.S. states increased in the fourth quarter of 2011, but their recent surge is tapering off, as they grew just 2.7 percent from the final quarter of 2010, according to a report released on Monday. "This is a noticeable slowdown from the 11.1 (percent) and 6.1 percent year-over-year growth reported in the second and third quarters of 2011, respectively," the Rockefeller Institute, a think tank that closely watches states' revenues, said in the report.

21 Mar 2012

Viewpoints: Rep. Ryan on his budget plan; Obama's contraceptive mandate could hurt McCaskill in tight Missouri race

On the critical issues of health security and tax reform, our budget draws a clear distinction between serious reformers and those who stand in the way of the growing bipartisan consensus for principled solutions. Our budget's Medicare reforms make no changes for those in or near retirement. For those who will retire a decade from now, our plan provides guaranteed coverage options financed by a premium-support payment. And this year, our budget adds even more choices for seniors, including a traditional fee-for-service Medicare option.

21 Mar 2012

Ampio completes partial planned interim review in Optina trial for diabetic macular edema

Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.

19 Mar 2012

Springer adds 6 new quarterly clinical review journals to medicine portfolio

Springer is adding six new quarterly clinical review journals to its existing medicine portfolio in March 2012. These new journals will expand the publisher's medical specialty coverage, focusing on dermatology, geriatrics/gerontology, nutrition, obesity, obstetrics/gynecology and respiratory care.

29 Feb 2012

Viewpoints: Contraception as Obama's 'gospel'; The right balance? Freedom at risk?; Examining Medicaid mandate

These guidelines, which increase access to contraceptive services for women while upholding the religious liberty of churches, mosques and synagogues, strike the proper balance between respecting the religious beliefs of all Americans and protecting the health of American women and families. They will reduce health costs, end long-standing gender discrimination in prescription drug coverage and further enable women to lead healthier lives.

13 Feb 2012

Researchers describe genetic basis of endometriosis

Researchers at Yale School of Medicine have, for the first time, described the genetic basis of endometriosis, a condition affecting millions of women that is marked by chronic pelvic pain and infertility. The researchers' discovery of a new gene mutation provides hope for new screening methods.

6 Feb 2012

Caffeine intake among women of child-bearing age influences estrogen levels

Asian women who consumed an average of 200 milligrams or more of caffeine a day-the equivalent of roughly two cups of coffee-had elevated estrogen levels when compared to women who consumed less, according to a study of reproductive age women by researchers at the National Institutes of Health and other institutions.

27 Jan 2012

Soligenix reports results from orBec Phase 2 trial on acute GVHD

Soligenix, Inc., a development stage biopharmaceutical company, announced the publication of results from its investigator-initiated Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.

12 Dec 2011

Ovary removal in younger women may lead to low-bone mineral density, arthritis

Having both ovaries removed before age 45 is strongly associated with low-bone mineral density and arthritis in later years, according to a new study by Johns Hopkins oncologists and epidemiologists. The analysis covered several thousand women who took part in a U.S. government-sponsored, multiyear national health study, and excluded women whose ovaries were removed due to cancer.

9 Dec 2011

Soligenix third quarter revenues increase to $5,796,000

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the third quarter of 2011.

14 Nov 2011

AHRQ: Only 8.7M of 12.1M women suffering from chronic pain received treatment in 2008

An estimated 12.1 million women age 18 and older reported suffering from chronic pain in 2008 as a result of underlying medical conditions such as chronic fatigue syndrome, endometriosis, fibromyalgia and vulvodynia. Of these women, only 8.7 million reported receiving treatment that year at a total cost of $12.9 billion, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

21 Oct 2011

AAGL to showcase innovative surgical approaches, teaching tools at 40th Global Congress

Technology has radically changed the way surgeons practice medicine, and nowhere is this more evident than in the field of gynecologic endoscopy. AAGL, the oldest professional organization devoted to teaching minimally invasive treatment for women's health problems, will showcase a number of innovative surgical approaches and teaching tools among the hundreds of postgraduate courses and practice labs offered at its annual Global Congress, November 6-11, 2011 at the Westin Diplomat in Hollywood, FL.

19 Oct 2011

Endometriosis News and Research

Latest Endometriosis News and Research

Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulthood

Ampio’s CRO completes Optina clinical trial for DME

Abbott commences elagolix Phase 3 trial in endometriosis

Urocortin 2 improves cardiac output in Phase II study for acute decompensated heart failure

KLF15 molecule inhibits action of estrogen in the endometrium

BP sunscreens may increase risk of endometriosis in women

Uterine cancer deaths rise 20% in the last decade

State lawmakers consider abortion, contraception legislation; Other states deal with fallout

Roundup: States face new revenue downturn; Calif. county has disparities in life expectancy

Viewpoints: Rep. Ryan on his budget plan; Obama's contraceptive mandate could hurt McCaskill in tight Missouri race

Ampio completes partial planned interim review in Optina trial for diabetic macular edema

Springer adds 6 new quarterly clinical review journals to medicine portfolio

Viewpoints: Contraception as Obama's 'gospel'; The right balance? Freedom at risk?; Examining Medicaid mandate

Researchers describe genetic basis of endometriosis

Caffeine intake among women of child-bearing age influences estrogen levels

Soligenix reports results from orBec Phase 2 trial on acute GVHD

Ovary removal in younger women may lead to low-bone mineral density, arthritis

Soligenix third quarter revenues increase to $5,796,000

AHRQ: Only 8.7M of 12.1M women suffering from chronic pain received treatment in 2008

AAGL to showcase innovative surgical approaches, teaching tools at 40th Global Congress

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Endometriosis News and Research

Latest Endometriosis News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in